Investing Profile

Daniel Wagner

Sr. Managing Director, Investments at Connecticut Innovations
Photo of Daniel Wagner, Managing Director at Connecticut Innovations

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Connecticut Innovations Network
17 CONNECTIONS
Connecticut Innovations Network
17 CONNECTIONS
Connecticut Innovations Network
17 CONNECTIONS
University of Dayton Network
16 CONNECTIONS
University of Dayton Network
16 CONNECTIONS
cb
Connecticut Innovations Managing Director
$150K - $7.0M
$3.5M
19
$4M

Sign in to see all 9 investments on record.

Sign in with Google →
Board Observer Medically HomePresent
Board Observer RallybioPresent
Board Member Tangen Biosciences, Inc.Present
Board Member BiorezPresent
Board Member AlloMek Therapeutics LLCPresent
Board Observer Azitra IncPresent
Sr. Managing Director, Investments Connecticut InnovationsPresent
Sr. Managing Director, Investments Connecticut InnovationsPresent
Investor Halda TherapeuticsPresent
Board Observer Simcha TherapeuticsPresent
Board Member ProteoWisePresent
Board Observer Artizan Biosciences, Inc.Present
Board Observer TastesNatural™, LLCPresent
Board Observer Tastes Natural, LLCPresent
Board Observer BEKHealthPresent
Board Observer Alphina TherapeuticsPresent
Board Observer CareSciencePresent
Board Observer Siduma TherapeuticsPresent
Board Observer RIGImmune Inc.Present
Board Observer RIGImmunePresent
Board Observer Manifest TechnologiesPresent
Board Member Intus BioPresent
Board Member Enrich Biosystems Inc.Present
Board Observer Revalia BioPresent
Board Member EncapsulatePresent
Investor Bexorg, Inc.Present
Consultant Connecticut InnovationsPresent
University of Dayton BS BS, Biology
University of Dayton BS Biology
Quinnipiac University MHS MHS, Biomedical Sciences
Quinnipiac University MHS Biomedical Sciences
Quinnipiac University Master of Business Administration - MBA Finance
Sign in with Google →
Sign in with Google →